Martha Foiani

1.8k total citations
23 papers, 855 citations indexed

About

Martha Foiani is a scholar working on Molecular Biology, Physiology and Neurology. According to data from OpenAlex, Martha Foiani has authored 23 papers receiving a total of 855 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 12 papers in Physiology and 11 papers in Neurology. Recurrent topics in Martha Foiani's work include Alzheimer's disease research and treatments (12 papers), Dementia and Cognitive Impairment Research (7 papers) and Genetic Neurodegenerative Diseases (3 papers). Martha Foiani is often cited by papers focused on Alzheimer's disease research and treatments (12 papers), Dementia and Cognitive Impairment Research (7 papers) and Genetic Neurodegenerative Diseases (3 papers). Martha Foiani collaborates with scholars based in United Kingdom, Sweden and United States. Martha Foiani's co-authors include Amanda Heslegrave, Henrik Zetterberg, Jonathan M. Schott, Jonathan D. Rohrer, Ashvini Keshavan, Nick C. Fox, Jamie Toombs, Philip S.J. Weston, Jason D. Warren and Michael P. Lunn and has published in prestigious journals such as Nature Communications, Neurology and Scientific Reports.

In The Last Decade

Martha Foiani

22 papers receiving 849 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Martha Foiani United Kingdom 18 408 312 256 211 158 23 855
Ronald Druyeh United Kingdom 6 307 0.8× 181 0.6× 262 1.0× 238 1.1× 140 0.9× 8 664
Hisatomo Kowa Japan 16 353 0.9× 275 0.9× 308 1.2× 85 0.4× 140 0.9× 69 895
Steffen Halbgebauer Germany 19 561 1.4× 443 1.4× 598 2.3× 294 1.4× 308 1.9× 46 1.3k
Barbara Polischi Italy 13 307 0.8× 290 0.9× 409 1.6× 169 0.8× 197 1.2× 21 774
Britta Brix Germany 17 617 1.5× 264 0.8× 268 1.0× 484 2.3× 238 1.5× 25 1.2k
Sydney V. Doss United States 9 247 0.6× 259 0.8× 112 0.4× 76 0.4× 130 0.8× 11 650
Eileen Ruth S. Torres United States 18 402 1.0× 281 0.9× 142 0.6× 47 0.2× 115 0.7× 30 1.1k
Amber Nolan United States 14 251 0.6× 166 0.5× 236 0.9× 167 0.8× 123 0.8× 31 727
Juliane Schelle Germany 8 326 0.8× 223 0.7× 163 0.6× 91 0.4× 142 0.9× 8 568

Countries citing papers authored by Martha Foiani

Since Specialization
Citations

This map shows the geographic impact of Martha Foiani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martha Foiani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martha Foiani more than expected).

Fields of papers citing papers by Martha Foiani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martha Foiani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martha Foiani. The network helps show where Martha Foiani may publish in the future.

Co-authorship network of co-authors of Martha Foiani

This figure shows the co-authorship network connecting the top 25 collaborators of Martha Foiani. A scholar is included among the top collaborators of Martha Foiani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martha Foiani. Martha Foiani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Foiani, Martha, et al.. (2026). Targeting tau in Alzheimer’s Disease: rationale, approach and challenges. Molecular Neurodegeneration. 21(1).
2.
Kamano, Naoko, Hiroki Sasaguri, Martha Foiani, et al.. (2025). Human MAPT knockin mouse models of frontotemporal dementia for the neurodegenerative research community. Cell Reports Methods. 5(4). 101024–101024. 1 indexed citations
3.
Kapoor, Mahima, Martha Foiani, Amanda Heslegrave, et al.. (2022). Association of plasma neurofilament light chain with disease activity in chronic inflammatory demyelinating polyradiculoneuropathy. European Journal of Neurology. 29(11). 3347–3357. 18 indexed citations
4.
Banerjee, Gargi, Niklas Forsgard, Gareth Ambler, et al.. (2021). Cerebrospinal fluid metallomics in cerebral amyloid angiopathy: an exploratory analysis. Journal of Neurology. 269(3). 1470–1475. 5 indexed citations
5.
Byrne, Lauren M., Filipe B. Rodrigues, Rosanna Tortelli, et al.. (2021). Brain-derived neurotrophic factor in cerebrospinal fluid and plasma is not a biomarker for Huntington’s disease. Scientific Reports. 11(1). 3481–3481. 21 indexed citations
6.
Weinhofer, Isabelle, Paulus Rommer, Bettina Zierfuss, et al.. (2021). Neurofilament light chain as a potential biomarker for monitoring neurodegeneration in X-linked adrenoleukodystrophy. Nature Communications. 12(1). 1816–1816. 36 indexed citations
7.
Woollacott, Ione, Jennifer M. Nicholas, Carolin Heller, et al.. (2020). Cerebrospinal Fluid YKL-40 and Chitotriosidase Levels in Frontotemporal Dementia Vary by Clinical, Genetic and Pathological Subtype. Dementia and Geriatric Cognitive Disorders. 49(1). 56–76. 29 indexed citations
8.
Banerjee, Gargi, Gareth Ambler, Ashvini Keshavan, et al.. (2020). Cerebrospinal Fluid Biomarkers in Cerebral Amyloid Angiopathy. Journal of Alzheimer s Disease. 74(4). 1189–1201. 45 indexed citations
9.
Guo, Tong, Karl Zimmerman, Martha Foiani, et al.. (2020). Plasma glial fibrillary acidic protein and neurofilament light chain, but not tau, are biomarkers of sports-related mild traumatic brain injury. Brain Communications. 2(2). fcaa137–fcaa137. 28 indexed citations
10.
Brinkmalm, Ann, Martha Foiani, Ione Woollacott, et al.. (2019). CSF synaptic protein concentrations are raised in those with atypical Alzheimer’s disease but not frontotemporal dementia. Alzheimer s Research & Therapy. 11(1). 105–105. 42 indexed citations
11.
Foiani, Martha, Claudia Cicognola, Natalia Ermann, et al.. (2019). Searching for novel cerebrospinal fluid biomarkers of tau pathology in frontotemporal dementia: an elusive quest. Journal of Neurology Neurosurgery & Psychiatry. 90(7). 740–746. 24 indexed citations
12.
Kapoor, Mahima, Martha Foiani, Amanda Heslegrave, et al.. (2019). Plasma neurofilament light chain concentration is increased and correlates with the severity of neuropathy in hereditary transthyretin amyloidosis. Journal of the Peripheral Nervous System. 24(4). 314–319. 54 indexed citations
13.
Sánchez‐Valle, Raquel, Amanda Heslegrave, Martha Foiani, et al.. (2018). Serum neurofilament light levels correlate with severity measures and neurodegeneration markers in autosomal dominant Alzheimer’s disease. Alzheimer s Research & Therapy. 10(1). 113–113. 54 indexed citations
14.
Paterson, Ross W., Catherine F. Slattery, Teresa Poole, et al.. (2018). Cerebrospinal fluid in the differential diagnosis of Alzheimer’s disease: clinical utility of an extended panel of biomarkers in a specialist cognitive clinic. Alzheimer s Research & Therapy. 10(1). 32–32. 105 indexed citations
15.
Zeitlberger, Anna Maria, Gilbert Thomas‐Black, Héctor García‐Moreno, et al.. (2018). Plasma Markers of Neurodegeneration Are Raised in Friedreich’s Ataxia. Frontiers in Cellular Neuroscience. 12. 366–366. 34 indexed citations
16.
Foiani, Martha, Ione Woollacott, Carolin Heller, et al.. (2018). Plasma tau is increased in frontotemporal dementia. Journal of Neurology Neurosurgery & Psychiatry. 89(8). 804–807. 44 indexed citations
17.
Woollacott, Ione, Jennifer M. Nicholas, Amanda Heslegrave, et al.. (2018). Cerebrospinal fluid soluble TREM2 levels in frontotemporal dementia differ by genetic and pathological subgroup. Alzheimer s Research & Therapy. 10(1). 79–79. 47 indexed citations
18.
Lashley, Tammaryn, Jonathan M. Schott, Philip S.J. Weston, et al.. (2018). Molecular biomarkers of Alzheimer's disease: progress and prospects. Disease Models & Mechanisms. 11(5). 159 indexed citations
19.
Kruse, Niels, Amanda Heslegrave, Vandana Gupta, et al.. (2018). Interlaboratory validation of cerebrospinal fluid α‐synuclein quantification in the diagnosis of sporadic Creutzfeldt‐Jakob disease. Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring. 10(1). 461–470. 6 indexed citations
20.
Toombs, Jamie, Martha Foiani, Ross W. Paterson, et al.. (2017). Effect of Spinal Manometers on Cerebrospinal Fluid Amyloid-β Concentration. Journal of Alzheimer s Disease. 56(3). 885–891. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ronald Druyeh Breakdown of academic impact, for papers by Hisatomo Kowa Breakdown of academic impact, for papers by Steffen Halbgebauer Breakdown of academic impact, for papers by Barbara Polischi Breakdown of academic impact, for papers by Britta Brix Breakdown of academic impact, for papers by Sydney V. Doss Breakdown of academic impact, for papers by Eileen Ruth S. Torres Breakdown of academic impact, for papers by Amber Nolan Breakdown of academic impact, for papers by Juliane Schelle
Rankless by CCL
2026